Related by context. All words. (Click for frequent words.) 76 Poster Presentations 76 Clinical Trial Results 75 Anticancer Drug 74 HCV Protease Inhibitor 74 Preclinical Data 73 Pooled Analysis 73 Late Breaker 72 Randomized Trials 72 Prolongs Survival 72 Drug Eluting 71 ASCO GI 71 Anticancer Activity 71 Survival Benefit 71 Adjuvant Chemotherapy 71 Inflammatory Arthritis 71 Targeted Therapies 71 Podium Presentation 70 Clinical Outcome 70 Therapeutic Vaccines 70 Poster Discussion 70 Clinical Trial Data 70 Osteoporosis Treatment 70 Nicotine Vaccine 70 Study Evaluating 70 Contrast Agents 70 Randomized Clinical Trial 70 Pharmacyclics Announces 70 Double Blind Placebo 70 Preclinical Study 70 Novel Therapies 70 AASLD Meeting 70 Hematological Malignancies 70 Nuvelo Announces 70 Meta Analysis 70 Acute Heart Failure 69 Anticancer Drugs 69 Small Molecule 69 Multiple Myeloma Patients 69 Liver Metastases 69 Kidney Transplant Patients 69 Present Preclinical Data 69 Potent Antiviral Activity 69 Oral Presentation 69 Colorectal Cancer Patients 69 Inflammatory Disease 69 Treating Depression 69 ICAAC IDSA 69 Beneficial Effects 69 Antitumor Activity 69 Phase 2b Clinical Trial 69 Viral Infections 69 Brain Metastases 69 Investigational Drug 69 Renal Cancer 69 Completes Patient Enrollment 69 Peer Reviewed Journal 69 Inflammatory Diseases 69 Lung Cancers 69 Long Term Outcomes 68 Cancer Stem Cells 68 Shows Efficacy 68 RNAi Therapeutic 68 Drug Candidate 68 Neoadjuvant Chemotherapy 68 FDA Approvals 68 Novel Antibiotic 68 ACR ARHP 68 Largest Database 68 Prognostic Value 68 Previously Treated 68 Cardiovascular Disease Risk 68 Poster Presentation 68 Novel Therapeutic 68 Nerve Regeneration 68 Gastric Cancer 68 Stent Thrombosis 68 Advanced Melanoma 68 Abstracts Accepted 68 Migraine Drug 68 Combination Treatment 68 Pharmacokinetic Study 68 Subgroup Analysis 68 Improves Survival 68 Protein Synthesis 68 Drug Shows Promise 68 Breast Cancer Recurrence 68 Autoimmune Disease 68 Oral Fingolimod 68 Novel Inhibitor 68 Patient Enrollment 68 Gout Drug 68 Renal Cell Carcinoma 68 Cancer Treatments 68 Proves Effective 68 Shows Promise Against 68 Demonstrates Efficacy 68 Shows Promising 68 Synthetic Peptide 68 Lupus Drug 68 Vitro Activity 68 Drug Combo 68 Pediatric Patients 68 Metastatic Melanoma 68 Imaging Techniques 68 Antithrombotic 68 RNAi Therapeutics 68 Lung Cancer Treatment 68 Protein Involved 68 Phase III Clinical Trial 67 Phase 2a Trial 67 Myeloma Patients 67 Rheumatoid Arthritis Patients 67 Therapeutic Antibody 67 AACR Meeting 67 Immunomedics Announces 67 Anti Tumor Activity 67 Randomized Controlled Trials 67 Hepatitis C Treatment 67 Lung Cancer Survival 67 Presents Preclinical Data 67 JAK Inhibitor 67 Breast Ultrasound 67 Adjuvant Breast Cancer 67 Randomized Double Blind 67 Liver Tumors 67 Completes Enrollment 67 Multicenter Phase 67 Cancer Immunotherapy 67 Phase 2b Trial 67 Preclinical Efficacy 67 Controlled Trial 67 Abstract Accepted 67 Immune Cell 67 Investigational Compound 67 Autoimmune Diseases 67 Newly Diagnosed 67 Vaccine Adjuvant 67 Phase IIb Clinical Trial 67 Newly Diagnosed Breast Cancer 67 Therapeutic Targets 67 Improved Survival 67 Patients Suffering 67 Emerging Therapies 67 Artery Disease 67 Kinase Inhibitor 67 Study Shows Benefits 67 Hematological Cancers 67 Demonstrates Significant 67 Tumor Microenvironment 67 Improve Survival 67 Kidney Transplants 67 Osteoporosis Drug 67 Patients Enrolled 67 Technological Advances 67 Treatment Regimen 67 Kidney Transplant Recipients 67 See CLINICAL PHARMACOLOGY 67 Lung Cancer Trial 67 Estrogen Therapy 67 Prostate Cancer Patients 67 Therapy Improves 67 ASH Annual Meeting 67 Placebo Controlled Trial 67 First Patient Dosed 67 Guidelines Recommend 67 Statin Therapy 67 Anti Tumor 67 Antipsychotic Drug 67 Lung Cancer Drug 67 Kinase Inhibitors 67 Hepatocellular Carcinoma 67 Oncology Compounds 67 Molecular Mechanisms 67 Phase III Clinical Trials 67 Stem Cell Transplants 67 Phase 2a Clinical Trial 67 Inflammatory Markers 67 Improves Outcomes 67 Treatment Reduces 67 Topical Treatment 67 HER2 Positive Breast Cancer 67 Receives Orphan Drug Designation 67 Systemic Sclerosis 67 Migraine Treatment 67 Randomized Clinical Trials 67 Preclinical Models 67 Orally Active 67 Novel Approach 67 Advanced Prostate Cancer 67 Treating Chronic 66 Multicenter Trial 66 Antiplatelet Therapy 66 Carotid Stenting 66 Selective Cardiac Myosin 66 Eye Diseases 66 Protease Inhibitor 66 Investigational Agent 66 Molecular Basis 66 Total Knee Arthroplasty 66 Annual ICAAC 66 Novel Mechanism 66 Novel Therapeutics 66 Effectively Treats 66 Ovarian Cancer Patients 66 Randomized Controlled 66 ECCMID 66 Refractory Angina 66 Ovarian Cancer Treatment 66 Patients Treated With 66 Controlled Study 66 Vaccine Adjuvants 66 Breast Tumors 66 Genes Linked 66 Mouse Model 66 Cardiotoxicity 66 Arterial Disease 66 Cholesterol Lowering Drug 66 Heart Failure Patients 66 Novel Approaches 66 Critically Ill Patients 66 Localized Prostate Cancer 66 Postmenopausal Women 66 Presents Positive 66 Coronary Revascularization 66 Key Milestones 66 Relapsing Multiple Sclerosis 66 Osteoporosis Drugs 66 SABCS 66 Spectrum Pharmaceuticals Announces 66 Initiates Clinical Trial 66 Image Guided 66 Schizophrenia Treatment 66 Randomized Phase III 66 Study Shows Significant 66 Subtypes 66 HER2 Positive 66 Anticancer Agent 66 Phase III Trials 66 Novel Oral 66 BiTE Antibody 66 Whole Genome Sequencing 66 Fungal Infections 66 Prognostic Factors 66 Genes Involved 66 FDA Okays 66 Rotavirus Vaccine 66 Demonstrates Sustained 66 Inflammatory Response 66 Dose Ranging Study 66 Laryngeal Cancer 66 Biological Therapy 66 II Clinical Trial 66 Prostate Cancer Vaccine 66 Prostate Cancer Treatment 66 Male Contraceptive 66 Tyrosine Kinase Inhibitor 66 Carotid Endarterectomy 66 Phase Ib Clinical Trial 66 Patients Undergoing 66 Technological Innovations 66 Erectile Dysfunction Drug 66 Genes Identified 66 Sangamo BioSciences Announces 66 Surgical Procedures 66 Therapeutic Potential 66 Menopausal Symptoms 66 Non Invasive Treatment 66 Treatment Naïve 66 Dosage Forms 66 Clinical Efficacy 66 Recurrent Breast Cancer 65 Cancer Therapies 65 Statin Drugs 65 Topline Results 65 Gastrointestinal Disorders 65 Bare Metal Stents 65 Rectal Cancer 65 Milestone Payment 65 Non Inferiority 65 Treated Patients 65 Asthma Treatment 65 AVI BioPharma Announces 65 Therapy Shows Promise 65 Adjunctive Treatment 65 Minimally Invasive Treatment 65 Bladder Cancer 65 Molecular Diagnostic Test 65 Myelodysplastic Syndromes 65 Hsp# Inhibitor 65 Investigational Treatment 65 FDA Approves Drug 65 Low Dose 65 VIVUS Qnexa 65 Hormone Refractory Prostate Cancer 65 Genetic Markers 65 Cancer Vaccines 65 Meets Primary Endpoint 65 Blood Cancers 65 Proves Successful 65 Randomized Double Blind Placebo 65 ASM Biodefense 65 Coronary Artery Calcium 65 Venous Thromboembolism 65 Obese Teens 65 Magnetic Nanoparticles 65 Epilepsy Drug 65 Detecting Breast Cancer 65 Novel Method 65 Contrast Agent 65 Combination REOLYSIN R 65 Biomarker Study 65 Sirolimus Eluting Stent 65 Disease Modifying 65 Chemotherapeutic Agents 65 Castration Resistant Prostate Cancer 65 Upcoming Conferences 65 Improving Patient Safety 65 Submits NDA 65 Receives Orphan Drug 65 Breast Carcinoma 65 Diagnostic Tests 65 Regimens 65 Slow Progression 65 Files IND 65 Less Invasive 65 Angiogenic 65 Cell Transplant 65 Interv 65 Lung Tumors 65 Eluting Stent 65 Artificial Pancreas 65 Obese Patients 65 Dose Response 65 Patients Treated 65 Appears Safe 65 Immune Responses 65 Bone Metastases 65 Kidney Function 65 Oral Mucositis 65 Diabetic Kidney Disease 65 Genes Associated 65 Protein Linked 65 Clinical Trial Evaluating 65 Preclinical Evaluation 65 Single Dose 65 Highly Selective 65 Prognostic Significance 65 Enlarged Prostate 65 Atypical Antipsychotics 65 Renal Tumors 65 Hematologic Malignancies 65 AAEP Convention 65 Hemodialysis Patients 65 Metastatic Renal Cell Carcinoma 65 Prostate Cancer Cells 65 Statistically Significant 65 Transdermal Patch 65 Novel Vaccine 65 Percutaneous Tibial Nerve Stimulation 65 Advanced Ovarian Cancer 65 Innovative Approaches 65 Anti Angiogenic 65 Diagnosis Treatment 65 Neoplasia 65 Antiviral Drugs 65 Ovarian Cancers 65 Diagnostic Criteria 65 Antiplatelet 65 Phase III Trial 65 Mouse Models 65 Antiviral Activity 65 Therapeutic Vaccine 65 Vascular Targeting Agents 65 Chronic Hepatitis C 65 Monoclonal Antibodies 65 Initiates Phase III 65 Confirmatory Phase 65 Gender Differences 65 Lowering Blood Pressure 65 Treatment Regimens 65 Proven Effective 65 Drug Fails 65 Guidelines Issued 65 Glaucoma Treatment 65 Urinary Incontinence 65 Overactive Bladder 65 Dose Escalation 65 Receives Approvable Letter 65 Stem Cell Treatment 65 Chemotherapy Regimen 65 Early Diagnosis 65 Upcoming Presentations 65 Chronic Lymphocytic Leukemia 65 Visceral Fat 64 Arthritis Drug 64 Randomized Study 64 CT Angiography 64 Combo Therapy 64 GRAS Status 64 Lumbar Spine 64 Lowers Risk 64 Biologic Therapy 64 Upcoming Webinar 64 Long Term Efficacy 64 Sleep Disturbances 64 Lowers Blood Pressure 64 Anti Inflammatory Drug 64 Surgical Treatment 64 Genes Predict 64 Blocked Arteries 64 Significant Improvement 64 Dendritic Cells 64 Improve Diagnosis 64 Respiratory Distress 64 Chronic Inflammation 64 Analytical Tool 64 Nanoemulsion 64 IND Filing 64 Reduce Mortality 64 Oral Cavity 64 Study Evaluates 64 Skin Lesions 64 Develop Novel 64 Solid Tumors 64 IND Application 64 Well Tolerated 64 Oral Insulin 64 Circulating Tumor Cells 64 Breast Cancer Cells 64 Significant Improvements 64 Slows Progression 64 Collaborators Present 64 Schizophrenia Drug 64 Retinal Diseases 64 Prenatal Diagnosis 64 Antibiotic Treatment 64 Neuroendocrine Tumors 64 Internationally Recognized 64 Colorectal Adenomas 64 Announces Poster Presentations 64 Demonstrates Potent 64 Patients Receiving 64 Postdoctoral Position 64 EntreMed Presents 64 Psoriasis Drug 64 Sinus Infections 64 Clostridium Difficile Infection 64 Crit Rev 64 Prospective Multicenter 64 Advanced Renal Cell 64 Epilepsy Drugs 64 Novel Treatments 64 Transplant Patients 64 Neuroprotective Effects 64 Malaria Vaccine 64 Cholesterol Lowering 64 Elderly Patients 64 Randomized Phase II 64 Myocardial Ischemia 64 Randomized Comparison 64 Chronic Hepatitis B 64 Surgical Techniques 64 Advanced Colorectal Cancer 64 Prolongs Life 64 Bazedoxifene 64 Previously Untreated 64 Showed Significant 64 Insulin Pen 64 Initiates Clinical 64 Differential Diagnosis 64 Lymph Nodes 64 Advanced Pancreatic Cancer 64 VIVUS Announces 64 Breast Brachytherapy 64 Systematic Approach 64 Weight Loss Drug 64 Non Invasive 64 Test Detects 64 Drug Prevents 64 Announces FDA Clearance 64 Treatment Approaches 64 Partial Onset Seizures 64 Latest Trends 64 Immune Cells 64 Prostate Cancers 64 Initiate Phase III 64 BioElectronics Announces 64 Cinacalcet 64 Pivotal Study 64 Drug Eluting Coronary Stent 64 Breast Exams 64 Successfully Completes Phase 64 Prospective Randomized 64 Phase IIb Trial 64 Pulmonary Arterial Hypertension 64 Adjuvant Treatment 64 Immunotherapeutic 64 Diabetic Neuropathy 64 Metastatic Cancer 64 Educational Webinar 64 Stent Implantation 64 Breast Cancer Stem Cells 64 Treatment Algorithm 64 Peripheral Blood 64 Fracture Risk 64 Preclinical Studies 64 Orphan Diseases 64 Study Proves 64 Pivotal Trials 64 Benign Prostatic Hyperplasia 64 Vaccine Protects Against 64 Relapsed Multiple Myeloma 64 Skin Cancers 64 Cholesterol Drugs 64 Radiation Dose 64 Clostridium difficile Infection 64 Stent Coating 64 Treatment Resistant 64 Safety Tolerability 64 Breast Cancer Patients 64 Antifungal 64 Systemic Delivery 64 Symptom Relief 64 Tissue Engineered 64 Prophylactic Treatment 64 Randomized Controlled Trial 64 Study Showed 64 Recombinant Protein 64 Hormone Receptor Positive 64 Platelet Inhibition 64 Seasonal Influenza Vaccine 64 Randomized Double blind 64 Brain Scans 64 Clinical Outcomes 64 Ultrasound Imaging 64 Gene Variants 64 Anticancer Compound 64 Lymph Node 64 Gene Mutation 64 REMINDER ORLive Presents 64 Renal Anemia 64 Cognitive Problems 64 Breast Density 64 Therapeutic Approaches 64 Cholesterol Drug 64 Intravenous Formulation 64 #st Annual Meeting 64 Hypertensive Patients 64 Prostate Biopsy 64 Excessive Sweating 64 Brentuximab Vedotin SGN 64 Colorectal Cancers 64 Cause Mortality 64 Gene Linked 63 Immune Mediated 63 Shown Effective 63 Device Helps 63 First Patient Enrolled 63 Immunodeficiencies 63 Prevent Stroke 63 Protease Inhibitors 63 Phase 2a Study 63 Anti Clotting Drug 63 Premature Infants 63 UEGW 63 Inhaled Liposomal Ciprofloxacin 63 Immunomodulatory 63 Aggressive Prostate Cancer 63 Knee Osteoarthritis 63 Trodusquemine MSI 63 Improve Outcomes 63 Anti Angiogenesis 63 Phase 2b Study 63 Survival Rate 63 Dose Ranging 63 Stent Restenosis 63 Metastatic Prostate Cancer 63 Bipolar Depression 63 Neural Stem Cells 63 AACR #st Annual Meeting 63 entitled Synergistic 63 Endometrial Cancer 63 Inhaled Insulin 63 Periodontal Disease 63 Industry Luminaries 63 Diagnostic Tools 63 Wide Array 63 Clinical Trial Enrollment 63 Kidney Transplantation 63 Stem Cell Procedure 63 Tezampanel 63 Significantly Improved 63 FDA Clears 63 Stereotaxis Announces 63 Lung Cancer Patients 63 Severe Sepsis 63 Gene Variation 63 ORLive Presents 63 Thrombolytic Therapy 63 Clinical Evaluation 63 Pharmacodynamics 63 Long Term Survival 63 Drug Coated Stents 63 Initiates Enrollment 63 HDAC Inhibitor 63 Hematological 63 Eur J 63 Nymox NX 63 Novel Small Molecule 63 Imaging Technique 63 Partial Nephrectomy 63 Patents Issued 63 Demonstrates Positive 63 Newly Diagnosed Multiple Myeloma 63 Molecular Mechanism 63 Randomized Phase 63 Confirms Efficacy 63 Outpatient Setting 63 Bioresorbable 63 Placebo Controlled Study 63 Healthcare Conferences 63 Osteoarthritis Patients 63 Cell Transplants 63 Method Developed 63 Novel Compounds 63 Diet Linked 63 Antibody Therapeutics 63 Versus Placebo 63 Volume Shipments 63 ASCO Breast Cancer 63 Helps Predict 63 Systematic Review 63 Upcoming Investor 63 Atopic Dermatitis 63 PDUFA Date 63 Hernia Repair 63 Content Outline 63 Invasive Breast Cancer 63 Bioartificial Liver 63 Sustained Efficacy 63 AACR San Antonio 63 Tablet Formulation 63 Heart Failure Therapy 63 Breaking Clinical Trials 63 Novel Biomarkers 63 Complicated Skin 63 Testosterone Patch 63 Resistant Hypertension 63 Critical Component 63 Small Molecules 63 Therapeutic Antibodies 63 Atrial Fibrillation Treatment 63 Prospective Randomized Study 63 Protein Structure 63 Oral Anticoagulant 63 Inuit Sculpture 63 Endometrial Ablation 63 XPEL Announces 63 Oligonucleotides 63 Antitumor 63 Recombinant Human 63 Malignant Mesothelioma 63 Protein Biomarker 63 Analytical Methods 63 Malignancies 63 Unapproved Drugs 63 Gastric Ulcers 63 Radical Prostatectomy 63 Adjuvant Therapy 63 Adjunctive Therapy 63 Patient Outcomes 63 Antibiotic Use 63 Study Validates 63 Cardiovascular Risk Reduction 63 Activator CK # 63 Preterm Labor 63 Brain Atrophy 63 Cholesterol Lowering Drugs 63 Diabetic Patients 63 Psoriasis Patients 63 Uterine Fibroid Embolization 63 Thought Provoking 63 Insulin Resistance 63 Glufosfamide 63 Profitable Third Quarter 63 Poniard Pharmaceuticals Announces 63 Male Infertility 63 Gastrointestinal Cancers Symposium 63 Breast Cancer Treatment 63 Liver Toxicity 63 ISPOR 63 CALL FOR ENTRIES 63 Histone Deacetylase 63 Cell Adhesion 63 Unfractionated Heparin 63 Valopicitabine NM# 63 Reduces Mortality 63 Protein Biomarkers 63 Breast Cancer Treatments 63 Tuberculosis Vaccine 63 Reduced Risk 63 Generic Versions 63 Blood Clotting 63 Investigator Initiated 63 Fewer Side Effects 63 Rheumatoid Arthritis Drug 63 Drug Formulation 62 Anti Infective 62 NanoMarkets Announces 62 Antiviral Therapy 62 Pharmaceuticals Initiates 62 Stem Cell Transplant 62 Unresectable 62 Drug Eluting Stents 62 Placebo Controlled 62 Most Widely Used 62 Endocrine Society Annual Meeting 62 Being Evaluated 62 Heart Failure Treatment 62 Hepatitis B Vaccine 62 Capsule Endoscopy 62 Catheter Ablation 62 Studies Suggest 62 Pivotal Phase III 62 Protein Interaction 62 Predict Risk 62 Coronary Intervention 62 Breast Tumor 62 Heart Stents 62 Lung Cancer Diagnosis 62 Granted Orphan Drug 62 Prostate Cancer Detection 62 FDA Accepts 62 #nd Annual Meeting 62 Cardiovasc 62 NOVAVAX 62 Treatment Naive Patients 62 Solid Malignancies 62 Pathogen Detection 62 MorphoSys AG MorphoSys 62 Hepatitis C Virus Infection 62 Antiviral Agents 62 Submission Deadline 62 Metabolic Disease 62 Neurosurg 62 Genetic Variants 62 Increased Mortality 62 Immunogenicity 62 Anemia Drug 62 Receives Milestone Payment 62 Brain Cells 62 BIOLASE Announces 62 Initiates Phase II 62 Multicenter Study 62 Oncologic 62 Contrast Enhanced 62 Porous Materials 62 Diabetic Nephropathy 62 CyberKnife Radiosurgery 62 Gene Mutations 62 Cervical Spine 62 Hospitalized Patients 62 NDA Submission 62 Helps Identify 62 Curr Opin 62 Adverse Outcomes 62 Cell Differentiation 62 Trial Evaluating 62 Genetic Variations 62 Commonly Used 62 Smooth Muscle 62 Corneal Transplant 62 ASGCT 62 Preclinical Testing 62 ANADIGICS Announces 62 Hematology Meeting 62 Minimally Invasive Procedure 62 Antipsychotic Drugs 62 #th Interscience Conference 62 Integra LifeSciences Announces 62 JAK2 Inhibitor 62 Venous Thrombosis 62 Intracranial Aneurysms 62 MRSA Infections 62 Key Attributes 62 Fecal Incontinence 62 Antiepileptic Drug 62 Drug Regimen 62 J Clin 62 Sustained Release 62 Advanced Solid Tumors 62 Study Demonstrates 62 Receives SFDA Approval 62 Boosts Survival 62 Cardiac Function 62 Cognitive Disorders 62 Autoimmune Disorders 62 Blood Pressure Drug 62 Node Positive 62 Demonstrates Statistically Significant 62 Genetic Disorders 62 Kidney Donors 62 First Patient Treated 62 Mitral Valve Repair 62 Capsules CII 62 Colorectal Screening 62 Patented Technology 62 Hepatitis C Virus 62 Commercially Available 62 Treatment Shows Promise 62 Stent Placement 62 Leukemia Cells 62 AnaSpec Introduces 62 Genetic Testing 62 Beta Blocker 62 Clinical Trials Update 62 Newly Diagnosed Patients 62 Phase III Pivotal Trial 62 Be Cured 62 Insulin Glargine 62 Polymerase Inhibitor 62 Treatment Naive 62 Crowd Pleasing 62 Endovascular Treatment 62 Signaling Pathways 62 Targeted Therapy 62 Elagolix 62 Toxicity Testing 62 Alternative Treatments 62 Demonstrates Potential 62 Fondaparinux 62 Fixed Dose 62 Microfluidic Devices 62 Phase 1b Clinical Trial 62 Liver Failure 62 Renal Cell Cancer 62 Pre Cancerous 62 Coronary Arteries 62 Clin Oncol 62 NPS Pharmaceuticals Announces 62 HDAC Inhibitors 62 Left Ventricular Hypertrophy 62 Collaborators Publish 62 Endothelial Function 62 Vitamin Supplements 62 Varicose Veins 62 Useful Tool 62 Autologous Stem Cell Transplantation 62 Migraine Sufferers 62 Wrinkle Treatment 62 Breast Cancers 62 Soft Tissue Sarcoma 62 Combination Therapy 62 Migraine Pain 62 Mortality Risk 62 Announces Presentation 62 Arthritis Drugs 62 Antigen Specific 62 Metastatic Colorectal Cancer 62 Relapsed Refractory 62 Allergic Reactions 62 Teva Provides Update 62 Seasonal Influenza 62 ASCO GU 62 Canon U.S.A. 62 Glatiramer Acetate 62 Postmenopausal Osteoporosis 62 Prospective Randomized Trial 62 Hospital Acquired Pneumonia 62 Minimally Invasive Spine Surgery 62 Statistical Significance 62 Bone Marrow Transplants 62 Announces Publication 62 Transdermal Delivery 62 Cervical Cancer Vaccine 62 Molecular Diagnostic 62 Stem Cell Breakthrough 62 Antigens 62 Disease Diagnosis 62 ANN INTERN MED 62 Dose Finding 62 lexidronam injection 62 Epidermal Growth Factor Receptor 62 Hematopoietic Stem Cell Transplantation 62 Surgical Mesh 62 Data Suggest 62 Novel Peptide 62 Mimetics 62 Significant Milestones 62 Cardiac Arrhythmias 62 Glycemic Control 62 Secondary Hyperparathyroidism 62 Hypercholesterolemia 62 Observational Studies 62 Blood Pressure Drugs 62 siRNA Delivery 62 Radiation Doses 62 Valvular Heart Disease 62 Malignant Melanoma 62 Serious Infections 62 Blood Pressure Lowering 62 Demonstrated Significant 62 Genetic Mutations 62 Speakers Announced 62 Receives FDA Clearance 62 Bone Grafting 62 Diabetic Foot Ulcer 62 Opioid Addiction 62 Therapeutic Monoclonal Antibodies 62 Growing Importance 62 Inhaled Corticosteroids 62 Acute Ischemic Stroke 62 Therapeutic Efficacy 62 Hormone Therapy 62 Ischemic Stroke 62 Novel Compound 62 Ebola Vaccine 62 Develops Novel 62 Inhaled Steroids 62 Cancer Therapeutic 62 Pandemic Influenza Vaccines 62 Prostate Screening 62 Issues Confronting 62 Weight Reduction 62 Fast Skeletal Troponin 62 Treatment Experienced 62 Recurrent Ovarian Cancer 62 Inherited Diseases 62 Findings Reveal 62 Metastatic Disease 62 Spider Silk 62 Knee Arthritis 62 Septic Shock 62 Flamel Technologies Announces 62 Creates Opportunities 62 Issued Patent 62 Commonly Prescribed 62 Patient Treated 61 Heart Failure Therapies 61 Dual Antiplatelet Therapy 61 Human Monoclonal Antibodies 61 Molecular Pathogenesis 61 Reports Preclinical Data 61 Could Save Lives 61 Pneumococcal Vaccine 61 Liver Fibrosis 61 Survival Rates 61 Metabolic Disorder 61 Single Molecules 61 Biologic Drugs 61 Needham Biotechnology 61 Achieves Unprecedented 61 Protein Microarray 61 Observational Study 61 Pancreatic Adenocarcinoma 61 Blood Vessels 61 Severe Asthma 61 Experimental Vaccine 61 Oral Insulin Capsule 61 Surgery Performed 61 Internationally Renowned 61 Migraine Headaches 61 DNA Methylation 61 Metabolic Disorders 61 Pregnancy Outcomes 61 Lung Cancer Vaccine 61 Recurrent Prostate Cancer 61 Successfully Treated 61 Gynecological Cancers 61 Renal Function 61 Drug Resistant Tuberculosis 61 Vertebral Fracture 61 Predict Response 61 Cardiometabolic 61 Myoblast 61 Hematology Molecular Pathology 61 Nerve Cell 61 Patents Covering 61 Often Misdiagnosed 61 Vitamin D Deficiency 61 Protein Expression 61 Webinar Focuses 61 OR Live.com Presents 61 MEK Inhibitor 61 Gold Nanorods 61 Stress Fractures 61 Cancer Recurrence 61 Cancer Biomarkers 61 Vertebral Fractures 61 Clot Risk 61 Oncolytic 61 Multicenter Randomized 61 Tigecycline 61 Bone Marrow Stem Cell 61 Lipid Levels 61 Thyroid Hormone 61 Gene Variant 61 Tumor Targeting 61 Pelvic Surgery